The instruction for medical use of IMPAZA medicine the Trade name of IMPAZA the International unlicensed name Is not present the Dosage form of the Tablet for resorption Structure One tablet contains active agent: Antibodies to endothelial NO to synthase affinely cleaned - 0.003 g*. excipients: lactoses monohydrate, cellulose microcrystalline, magnesium stearate. * are applied on lactoses monohydrate in the form of aqueous-alcoholic mix with contents no more than 10-15 ng/g an active form of active ingredient. The description of the Tablet of a ploskotsilindrichesky form with risky and a facet, from white till almost white color. On the flat party from risky the inscription MATERIA MEDICA is put, on other flat party the inscription IMPAZA is put. Pharmacotherapeutic group Drugs for treatment of disturbances of an erection. The ATX G04BE code the Pharmacological Pharmacokinetics Due to properties the maintenance of midget doses of active ingredients in drug, is not possible to conduct pharmacokinetic researches. The pharmacodynamics Increases activity endothelial NO of synthase, restores development by an endothelium of nitrogen oxide (NO) at sexual stimulation, increases contents in unstriated muscles cyclic guanine riboside-monophosphate (tsGMF) and promotes their relaxation that leads to increase in a krovenapolneniye of cavernous bodies and provides an erection, sufficient on force and duration. Drug raises a libido (sexual desire) and satisfaction with sexual intercourse. Regular use of drug promotes increase in content of testosterone in serum (at moderately reduced initial level). Indications of Disturbance of an erection (erectile dysfunction) of various origin. Vegetative disorders of a climacteric at men (weakness, fatigue, decrease in physical activity, decrease in a libido, etc.). A route of administration and doses On one reception - 1 tablet (to hold in a mouth before full dissolution - not during meal). Regular reception. For stabilization of sexual potency (ability to sexual intercourse) the treatment-and-prophylactic course lasting not less than 12 weeks is recommended. Depending on severity of erectile dysfunction the frequency of reception can vary: from 1 tablet every other day to two receptions on a tablet daily, it is desirable in the evening. If necessary course therapy can be repeated in 3-6 months. Periodic reception. For incidental stimulation of an erection the drug is taken before sexual intercourse on 2 tablets in 1-2 hours. Side effects - allergic reactions of the Contraindication the Increased individual sensitivity to drug components. Medicinal interactions Impaza's use against the background of intake of nitrates for patients with coronary heart disease (angina of exertion of the I-II functional class) and also use together with beta blockers, diuretics, inhibitors of the angiotensin-converting enzyme (ACE), antagonists of calcium is possible. Special instructions monohydrate in this connection patients are not recommended to appoint it with a congenital galactosemia, a sprue of glucose or a galactose, or with a congenital lactose intolerance is a part of drug lactoses. Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms Drug does not affect ability to run motor transport and potentially dangerous mechanisms Overdose Symptoms – At accidental overdose the dispepsichesky phenomena caused by the fillers which are a part of a dosage form are possible. Treatment – symptomatic therapy the Form of release and packing of the Tablet for resorption. On 20 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil. On 1 blister strip packaging together with the instruction for medical use in the state and Russian languages place in a pack from cardboard. Storage conditions At a temperature not above 25 °C. To store out of children's reach! 3 years not to apply a period of storage after an expiration date. Prescription status Without prescription LLC NPF MATERIA MEDIKA HOLDING Producer, Russia, 127473, Moscow, 3rd Samotechny Lane, 9. Ph./fax: (495) 684-43-33. Owner of the registration certificate of LLC NPF MATERIA MEDIKA HOLDING, Russia. The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products Representative office of LLC NPF MATERIA MEDIKA HOLDING in RK Almaty, Zhibek St. of a zhola 64, office 206. Ph./fax: 2734713 E-mail: materiamedica.kz@mail.ru
Related Products
